journal
Journals Basic & Clinical Pharmacology ...

Basic & Clinical Pharmacology & Toxicology

https://read.qxmd.com/read/38622813/copper-from-enigma-to-therapeutic-target-for-neurological-disorder
#1
REVIEW
Jayant Patwa, Swaran Jeet Singh Flora
Neurological disorders (NDs) have a negative impact on the lives of individuals. There could be two explanations for this: unclear aetiology and lack of effective therapy. However, research in the past few years has revealed the role of bio-metals dyshomeostasis in NDs. The imbalance in copper (Cu) concentration may be one of the main causative factors in NDs. In this review, we have discussed the role of Cu in NDs, especially Alzheimer's disease (AD), including the molecular mechanisms involved in Cu-associated NDs like oxidative stress, neuroinflammation, and protein misfolding...
April 15, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38599832/exploring-clozapine-pharmacokinetics-in-tunisian-schizophrenic-patients-a-population-based-modelling-approach-investigating-the-impact-of-genetic-and-non-genetic-variables
#2
JOURNAL ARTICLE
Khadija Mansour, Nadia Ben Fredj, Helmi Ammar, Haifa Ben Romdhane, Ahmed Mhalla, Amel Chaabane, Zohra Chadli, Karim Aouam
Clozapine is characterized by a large within- and between-patient variability in its pharmacokinetics, attributed to non-genetic and genetic factors. A cross-sectional analysis of clozapine trough concentration (Clz C0) issued from Tunisian schizophrenic patients was collected and analysed using a nonparametric modelling approach. We assessed the impact of demographic covariates (age, weight and sex), patient's habits (smoking status, alcohol and caffeine intake) and the genetic factors (CYP1A2*1C, CYP1A2*1F and CYP2C19*2 polymorphisms) on each pharmacokinetic parameter...
April 10, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38584299/effects-of-sex-and-hydration-status-on-kappa-opioid-receptor-mediated-diuresis-in-rats
#3
JOURNAL ARTICLE
Hasnain M Lalji, Christopher P Bailey, Stephen M Husbands, Sarah J Bailey
Understanding the function of the kappa opioid receptor (KOP) is crucial for the development of novel therapeutic interventions that target KOP for the treatment of pain, stress-related disorders and other indications. Activation of KOP produces diuretic effects in rodents and man. Sex is a vital factor to consider when assessing drug response in pre-clinical and clinical studies. In this study, the diuretic effect of the KOP agonist, U50488 (1-10 mg/kg), was investigated in both adult female and male Wistar rats that were either normally hydrated or water-loaded...
April 7, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38583870/optimizing-myocardial-cell-protection-with-xanthine-derivative-kmup-3-potentiates-autophagy-through-the-pi3k-akt-enos-axis
#4
JOURNAL ARTICLE
Shang-En Huang, Jong-Hau Hsu, Bo-Wen Shiau, Yi-Ching Liu, Bin-Nan Wu, Zen-Kong Dai, Chung-Pin Liu, Jwu-Lai Yeh
BACKGROUND: Autophagy can have either beneficial or detrimental effects on various heart diseases. Pharmacological interventions improve cardiac function, which is correlated with enhanced autophagy. To assess whether a xanthine derivative (KMUP-3) treatment coincides with enhanced autophagy while also providing cardio-protection, we investigated the hypothesis that KMUP-3 treatment activation of autophagy through PI3K/Akt/eNOS signalling offered cardioprotective properties. METHODS: The pro-autophagic effect of KMUP-3 was performed in a neonatal rat model targeting cardiac fibroblasts and cardiomyocytes, and by assessing the impact of KMUP-3 treatment on cardiotoxicity, we used antimycin A-induced cardiomyocytes...
April 7, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38566316/exploring-promising-minor-natural-phenolic-compounds-in-neuroprotection-related-preclinical-models
#5
REVIEW
Carlos Franciney Moreira Vasconcelos, Agnieszka Zofia Neugebauer, Ricardo Basto Souza
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterised by the progressive loss of specific neuronal cell populations due to multifactorial factors, including neurochemical and immunological disturbances. Consequently, patients can develop cognitive, motor and behavioural dysfunctions, which lead to impairments in their quality of life. Over the years, studies have reported on the neuroprotective properties inherent in phenolic compounds. Therefore, this review highlights the most recent scientific findings regarding phenolic compounds as promising neuroprotective molecules against neurodegenerative diseases...
April 2, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38520199/dimetindene-is-the-minimum-toxic-dose-for-children-too-strict
#6
JOURNAL ARTICLE
Michal Čečrle, Daniela Pelclová, Navrátil Tomáš, Sergej Zacharov
Dimetindene is a sedating antihistamine indicated for the symptomatic treatment of allergic conditions. Dimetindene is marketed among others under the trade name Fenistil (oral solution). Toxicity data are limited, and there is no consensus on the dose at which children require hospitalization. Objective is to determine the potentially toxic dose in children. Data in children with age up to 15 years were obtained from hospital discharge reports. Of 139 paediatric hospital discharge reports, 23 cases (16...
March 23, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38506371/population-pharmacokinetics-of-oxcarbazepine-active-metabolite-in-chinese-paediatric-patients-with-epilepsy-model-based-dose-optimization
#7
JOURNAL ARTICLE
Wei Wu, Wen-Sheng Yang, Xiao-Yong Xu, Xi-Lin Ge, Jinmiao Lu, Guang-Fei Wang, Yi Wang, Zhi-Ping Li
The pharmacological activity of oxcarbazepine (OXC) is primarily exerted through its active 10-monohydroxy metabolite (MHD). Nonetheless, there is limited pharmacokinetic information available regarding paediatric patients with epilepsy treated with OXC, especially in infants and toddlers. Concurrently, this drug exhibits substantial variability in pharmacokinetics and therapeutic response across different individuals. We aimed to develop a model to quantitatively investigate factors that affect MHD pharmacokinetics to formulate a dosage guideline for OXC in Chinese paediatric patients...
March 20, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38504615/population-pharmacokinetic-pharmacodynamic-model-of-subcutaneous-bupivacaine-in-a-novel-extended-release-microparticle-formulation
#8
JOURNAL ARTICLE
Ida Klitzing Storgaard, Elisabeth Kjaer Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg, Mike Allan Royal, Kirsten Møller, Mads Utke Werner, Trine Meldgaard Lund
The objective of this study was to develop a population pharmacokinetic-pharmacodynamic model of subcutaneously administered bupivacaine in a novel extended-release microparticle formulation for postoperative pain management. Bupivacaine was administered subcutaneously in the lower leg to 28 healthy male subjects in doses from 150 to 600 mg in a phase 1 randomized, placebo-controlled, double-blind, dose-ascending study with two different microparticle formulations, LIQ865A and LIQ865B. Warmth detection threshold was used as a surrogate pharmacodynamic endpoint...
March 20, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38501576/small-molecule-inhibitor-hi-topk-032-improves-nk-92mi-cell-infiltration-into-ovarian-tumours
#9
JOURNAL ARTICLE
Mengqi Deng, Ruiye Yang, Qi Sun, Jiamin Zhang, Jinwei Miao
The effectiveness of natural killer (NK) cells transferred adoptively in combating solid tumours is limited by challenges such as their difficulty in penetrating tumours from the bloodstream and maintaining viability without the support of interleukin-2 (IL-2). Genetically modified NK-92MI cells, which can release IL-2 to sustain their viability, have been identified as a promising alternative. This adaptation addresses the negative consequences of systemic IL-2 administration. The role of PSD-95/discs large/ZO-1 (PDZ)-binding kinase (PBK) in cancer development is recognized, but its effects on immunity are not fully understood...
March 19, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38482995/dose-safety-and-pharmacodynamics-of-subcutaneous-bupivacaine-in-a-novel-extended-release-microparticle-formulation-a-phase-1-dose-ascending-study-in-male-volunteers
#10
JOURNAL ARTICLE
Elisabeth Kjaer Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg, Mike Allan Royal, Ida Klitzing Storgaard, Trine Meldgaard Lund, Kirsten Møller, Mads Utke Werner
A novel microparticle-based extended-release local anaesthetic containing a bupivacaine/poly-lactic-co-glycolic acid (PLGA; LIQ865A) or plain bupivacaine (LIQ865B) was examined in a first-in-human trial. The objectives were to examine the dose safety/tolerability and pharmacodynamics. Randomized subcutaneous injections of LIQ865A (n = 16) or LIQ865B (n = 12) and diluent, contralaterally, were administered in a dose-ascending manner (150- to 600-mg bupivacaine). Subjects were admitted 24 h post-injection and followed for 30 days post-injection...
March 14, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38482977/a-review-on-the-new-age-methodologies-for-early-detection-of-alzheimer-s-and-parkinson-s-disease
#11
REVIEW
Nabanita Ghosh, Krishnendu Sinha, Parames C Sil
BACKGROUNDS: Neurodegenerative diseases (NDDs) such as Alzheimer's (AD) and Parkinson's (PD) are often diagnosed late, impeding effective treatment; therefore, early detection is imperative. Modern methodologies can serve a pivotal role in fulfilling the crucial need for timely detection and intervention in this context. OBJECTIVES: Evaluate early detection's significance and summarize key technologies (biomarkers, neuroimaging, AI/ML, genetics, digital health) for enhanced diagnostic strategies in AD and PD...
March 14, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38477419/therapeutic-applicability-of-cannabidiol-and-other-phytocannabinoids-in-epilepsy-multiple-sclerosis-and-parkinson-s-disease-and-in-comorbidity-with-psychiatric-disorders
#12
REVIEW
Maria de Fátima Dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, Messias Gonzaga Pereira, Norberto Cysne Coimbra
Studies have demonstrated the neuroprotective effect of cannabidiol (CBD) and other Cannabis sativa L. derivatives on diseases of the central nervous system caused by their direct or indirect interaction with endocannabinoid system-related receptors and other molecular targets, such as the 5-HT1A receptor, which is a potential pharmacological target of CBD. Interestingly, CBD binding with the 5-HT1A receptor may be suitable for the treatment of epilepsies, parkinsonian syndromes and amyotrophic lateral sclerosis, in which the 5-HT1A serotonergic receptor plays a key role...
March 13, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38477401/a-novel-approach-combining-network-pharmacology-and-experimental-validation-to-study-the-protective-effect-of-ginsenoside-rb1-against-cantharidin-induced-hepatotoxicity-in-mice
#13
JOURNAL ARTICLE
Lijuan Xiong, Kexin Lin, Tianmu He, Xingyan Liu, Rui Yuan, Xiaofei Li, Jianyong Zhang
Cantharidin (CTD) is a widely used anticancer compound, but its clinical use is mainly limited due to hepatotoxicity. Ginsenoside Rb1 (GRb1) shows potential hepatoprotective effects. Nonetheless, the protective effect and underlying mechanism of GRb1 against CTD-induced hepatotoxicity in mice have not been investigated. This study aims to elucidate the effect and mechanism of GRb1 on CTD-induced hepatotoxicity using network pharmacology and in vivo experiments. Network pharmacology studies have shown that 263 targets were the main mechanisms by which GRb1 alleviates CTD-induced hepatotoxicity...
March 13, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38468413/matrix-metalloproteinases-are-associated-with-severity-of-disease-among-covid-19-patients-a-possible-pharmacological-target
#14
JOURNAL ARTICLE
Gisele Lopes Cavalcante, Lívia Pimenta Bonifacio, Jéssica Maria Sanches-Lopes, Fernanda Guioti Puga, Felipe Santos de Carvalho, Fernando Bellissimo-Rodrigues, Jose Eduardo Tanus-Santos
COVID-19 is a devastating disease and imbalanced matrix metalloproteinase (MMP) activity may contribute to its pathophysiology. This exploratory study examined whether increased circulating concentrations of MMP-2 and MMP-9, and their endogenous inhibitors, the tissue inhibitors of MMP (TIMP)-1, TIMP-2, TIMP-3 and TIMP-4 are persistently found in patients 2 weeks after their recovery from severe or critical COVID-19 as compared with those in healthy controls. Subjects who had severe (n = 26) or critical (n = 25) PCR-confirmed COVID-19 and healthy controls (n = 21) had blood samples drawn 2 weeks after recovery and serum MMP-2, MMP-9, TIMP-1, TIMP-2, TIMP-3 and TIMP-4 were determined using two Human Luminex® Discovery Assays...
March 11, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38459754/dementia-and-depression-biological-connections-with-amyloid-%C3%AE-protein
#15
REVIEW
Helamã Moraes Dos Santos, Amanda Gollo Bertollo, Maiqueli Eduarda Dama Mingoti, Roberta Eduarda Grolli, Kelli Maria Kreuz, Zuleide Maria Ignácio
Dementia is an umbrella term for a broad group of age-associated neurodegenerative diseases. It is estimated that dementia affects 50 million people worldwide and that Alzheimer's disease (AD) is responsible for up to 75% of cases. Small extracellular senile plaques composed of filamentous aggregates of amyloid β (Aβ) protein tend to bind to neuronal receptors, affecting cholinergic, serotonergic, dopaminergic and noradrenergic neurotransmission, leading to neuroinflammation, among other pathophysiologic processes and subsequent neuronal death, followed by dementia...
March 8, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38439200/the-glucocorticoid-dexamethasone-alleviates-allergic-inflammation-through-a-mitogen-activated-protein-kinase-phosphatase-1-dependent-mechanism-in-mice
#16
JOURNAL ARTICLE
Tiina Lehtola, Elina Nummenmaa, Riina Nieminen, Mari Hämäläinen, Katriina Vuolteenaho, Eeva Moilanen
Glucocorticoids are widely used in the treatment of allergic and inflammatory diseases. Glucocorticoids have a widespread action on gene expression resulting in their pharmacological actions and also an array of adverse effects which limit their clinical use. It remains, however, to be studied which target gene effects are essential for the anti-allergic activity of glucocorticoids. Mitogen-activated protein kinase phosphatase-1 (MKP-1) inhibits proinflammatory signalling by suppressing the activity of mitogen activated protein kinase (MAP kinase) pathways...
March 4, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38426366/perineuronal-nets-as-regulators-of-parvalbumin-interneuron-function-factors-implicated-in-their-formation-and-degradation
#17
JOURNAL ARTICLE
Thamyris Santos-Silva, Debora A E Colodete, João Roberto Fernandes Lisboa, Ícaro Silva Freitas, Caio Fábio Baeta Lopes, Victor Hadera, Thaís Santos Almeida Lima, Adriana Jesus Souza, Felipe V Gomes
The brain extracellular matrix (ECM) has garnered increasing attention as a fundamental component of brain function in a predominantly "neuron-centric" paradigm. Particularly, the perineuronal nets (PNNs), a specialized net-like structure formed by ECM aggregates, play significant roles in brain development and physiology. PNNs enwrap synaptic junctions in various brain regions, precisely balancing new synaptic formation and long-term stabilization, and are highly dynamic entities that change in response to environmental stimuli, especially during the neurodevelopmental period...
March 1, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38409617/four-weeks-sglt2-inhibition-improves-beta-cell-function-and-glucose-tolerance-without-affecting-muscle-free-fatty-acid-or-glucose-uptake-in-subjects-with-type-2-diabetes
#18
JOURNAL ARTICLE
Jens Hohwü Voigt, Katrine M Lauritsen, Steen Bønløkke Pedersen, Troels K Hansen, Niels Møller, Niels Jessen, Marcello C Laurenti, Chiara Dalla Man, Adrian Vella, Lars C Gormsen, Esben Søndergaard
AIMS: Sodium glucose co-transporter-2 (SGLT2) inhibition lowers glucose levels independently of insulin, leading to reduced insulin secretion and increased lipolysis, resulting in elevated circulating free fatty acids (FFAs). While SGLT2 inhibition improves tissue insulin sensitivity, the increase in circulating FFAs could reduce insulin sensitivity in skeletal muscle and the liver. We aimed to investigate the effects of SGLT2 inhibition on substrate utilization in skeletal muscle and the liver and to measure beta-cell function and glucose tolerance...
February 26, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38409579/characteristics-of-%C3%AE-1-adrenoceptor-antagonists-induced-ejaculatory-dysfunction-on-spontaneous-seminal-emission-in-rats
#19
JOURNAL ARTICLE
Masaru Yoshizumi, Shin-Nosuke Ise, Akihiko Yonezawa, Chizuko Watanabe, Shinobu Sakurada, Hirokazu Mizoguchi
Although α1 -adrenoceptor (α1 -AR) antagonists used to treat benign prostatic hyperplasia can cause ejaculation disorders, the aetiology of this adverse event is still controversial. Therefore, we investigated the effects of antagonists with different affinities for α1 -AR subtypes on ejaculatory function and their mechanisms of action in normal rats. In the spontaneous seminal emission (SSE) test, systemically administered prazosin, terazosin, tamsulosin and naftopidil decreased the weight of ejaculated seminal material in a dose-dependent manner; the potency order was as follows: tamsulosin > terazosin > prazosin > naftopidil...
February 26, 2024: Basic & Clinical Pharmacology & Toxicology
https://read.qxmd.com/read/38403838/pharmacogenetic-testing-of-cyp2d6-cyp2c19-and-cyp2c9-in-denmark-agreement-between-publicly-funded-genotyping-tests-and-the-subsequent-phenotype-classification
#20
JOURNAL ARTICLE
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
No abstract text is available yet for this article.
February 25, 2024: Basic & Clinical Pharmacology & Toxicology
journal
journal
40644
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.